arrow
V

Véronique Avettand-Fènoël

Universite d'Orleans
H指数:47
被引数:8,411

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Major Depressive Episodes and Psychiatric Symptoms Among HIV Controllers Compared With Antiretroviral-Treated People Living With HIV

与接受抗逆转录病毒治疗的HIV感染者相比,HIV控制者中重度抑郁发作和精神症状的情况

2026-09-300
OAAI
Constitutive natural killer cell features associated with post-treatment control of SIV infection in the pVISCONTI study

pVISCONTI研究中与治疗后控制SIV感染相关的固有自然杀伤细胞特征

2026-08-220
OAAI
A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab

法国全国性真实世界调查:接受含fos-temsavir或ibalizumab的抗逆转录病毒方案的多耐药HIV-1病毒感染者

2026-08-140
OAAI
Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption

治疗后SIV控制与治疗前及治疗中断后的病毒持续存在特征相关

2026-02-270
OAAI
HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir

基于dolutegavir治疗的组织中HIV持久性与dolutegavir耐药突变无关

2026-01-270
OAAI
Benefits of HIV-1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co-evolution of recent circulating recombinant forms 94 and 132

HIV-1传播簇监测的益处:一项关于近期流行重组型94和132分子与流行病学协同演化的法国回顾性观察研究

2025-01-281
OAAI
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
2024-09-024
PRE
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine
2024-06-170
PRE
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells

早期抗逆转录病毒治疗有利于与增强的记忆CD8 T细胞扩增相关的治疗后SIV控制

2024-01-1114
OAAI
Genetically determined thymic function affects strength and duration of immune response in COVID patients with pneumonia

遗传决定的胸腺功能影响肺炎COVID患者免疫反应的强度和持续时间

2023-09-224
OAAI
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study
2023-05-301
OAAI